HeartSciences Inc.
HSCS
$3.08
$0.269.22%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.52% | -20.28% | -32.70% | -33.26% | -25.20% |
| Total Depreciation and Amortization | 2.39% | 24.41% | 34.60% | -29.81% | -25.73% |
| Total Amortization of Deferred Charges | 585.01% | 282.24% | 176.06% | 69.88% | 4.58% |
| Total Other Non-Cash Items | 95.69% | -22.05% | -49.98% | -62.48% | -31.94% |
| Change in Net Operating Assets | 86.06% | 231.31% | 202.68% | 140.75% | -550.44% |
| Cash from Operations | 4.84% | -9.92% | -22.12% | -16.43% | -49.41% |
| Capital Expenditure | 78.62% | 95.04% | 95.04% | -123.18% | -237.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 58.01% | 52.38% | 55.59% | 1.98% | -- |
| Cash from Investing | 67.92% | 75.17% | 75.98% | -43.64% | -594.44% |
| Total Debt Issued | -100.00% | 453.65% | 453.65% | 453.65% | 453.65% |
| Total Debt Repaid | -187.29% | -30.46% | 9.40% | 21.26% | 39.98% |
| Issuance of Common Stock | -94.25% | -94.83% | -88.86% | -87.66% | 332.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -54.53% | -44.84% | -73.57% | -73.97% | 416.21% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -153.16% | -141.11% | -213.56% | -187.06% | 232.80% |